Individualized Tumor Specific TCR-T Cells

tumor-specific T-cell receptor engineered T cells (TCR-T) · Guangzhou FineImmune Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Individualized Tumor Specific TCR-T Cells, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Individualized Tumor Specific TCR- T Cells in the Treatment of Advanced Solid Tumors [Phase 1]